European Medicines Agency finds AstraZeneca shot can cause rare blood clots with low platelet count

The safety committee of the European Medicines Agency (EMA) has found that the Oxford-AstraZeneca Covid-19 vaccine can cause unusual blood clots with low blood platelets, but stresses the overall benefits of the vaccine in preventing coronavirus outweigh the risks of side effects.

“EMA is reminding healthcare professionals and people receiving the vaccine to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within 2 weeks of vaccination,” the agency said in a statement Wednesday.

“So far, most of the cases reported have occurred in women under 60 years of age within 2 weeks of vaccination. Based on the currently available evidence, specific risk factors have not been confirmed.”

This is a breaking story, more to follow…